oa SA Pharmaceutical Journal - Drug-induced osteoporosis : review

Volume 77, Issue 9
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Osteoporosis remains a largely silent and under-diagnosed disease. As few as one in five women with an osteoporotic fracture may receive treatment. It is defined as a reduction in the strength of bone via low bone mass and microarchitectural deterioration leading to an increased risk of fractures. The World Health Organization (WHO) defines osteoporosis as a bone density falling 2.5 standard deviations below the mean for a young healthy adult of the same gender.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error